{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:05:32Z","timestamp":1794557132482,"version":"4.9.1"},"reference-count":162,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.nano.2009.04.008","type":"journal-article","created":{"date-parts":[[2009,5,16]],"date-time":"2009-05-16T08:27:41Z","timestamp":1242462461000},"page":"9-24","source":"Crossref","is-referenced-by-count":647,"title":["Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery"],"prefix":"10.1016","volume":"6","author":[{"given":"B.","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavesh B.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2009.04.008_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jsurg.2007.11.006","article-title":"For the surgeon: an introduction to nanotechnology","volume":"65","author":"Asiyanbola","year":"2008","journal-title":"J Surg Educ"},{"key":"10.1016\/j.nano.2009.04.008_bib2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.urolonc.2007.03.017","article-title":"New frontiers in nanotechnology for cancer treatment","volume":"26","author":"Alexis","year":"2008","journal-title":"Urol Oncol"},{"key":"10.1016\/j.nano.2009.04.008_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nano.2005.06.004","article-title":"Role of nanotechnology in targeted drug delivery and imaging: a concise review","volume":"1","author":"Koo","year":"2005","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2009.04.008_bib4","doi-asserted-by":"crossref","DOI":"10.1109\/ICMENS.2003.1221969","article-title":"Smart Materials: Applications of nanotechnology in drug delivery and drug targeting","author":"Lobenberg","year":"2003"},{"key":"10.1016\/j.nano.2009.04.008_bib5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11481-006-9032-4","article-title":"Nanotechnology: a focus on nanoparticles as a drug delivery system","volume":"1","author":"Kingsley","year":"2006","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.nano.2009.04.008_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.copbio.2007.01.006","article-title":"Nanotechnological applications in medicine","volume":"18","author":"Caruthers","year":"2007","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.nano.2009.04.008_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2014a review of the state of the art","volume":"50","author":"Mueller","year":"2000","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2009.04.008_bib8","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/nbt876","article-title":"Small-scale system for in-vivo drug delivery","volume":"21","author":"La-Van","year":"2003","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nano.2009.04.008_bib9","first-page":"124","article-title":"Second generation of drug nanocrystals for delivery of poorly soluble drugs: smart crystals technology","volume":"24","author":"Keck","year":"2008","journal-title":"DSOIS"},{"key":"10.1016\/j.nano.2009.04.008_bib10","first-page":"257","article-title":"Nanofabrication for drug delivery and tissue engineering","volume":"3","author":"Shrivastava","year":"2008","journal-title":"DJNB"},{"key":"10.1016\/j.nano.2009.04.008_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0939-6411(97)00150-1","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2013drug release and release mechanism","volume":"45","author":"Muhlen","year":"1998","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2009.04.008_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles\u2014production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2009.04.008_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0168-3659(01)00230-9","article-title":"Design of rolipram-loaded nanoparticles: comparison of two preparation methods","volume":"71","author":"Lamprecht","year":"2001","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijpharm.2005.08.008","article-title":"Ibuprofen-loaded nanoparticles prepared by a co-precipitation method and their release properties","volume":"304","author":"Jiang","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0378-5173(02)00147-3","article-title":"Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution","volume":"242","author":"Chen","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib16","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3109\/03639049809108571","article-title":"Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers","volume":"24","author":"Quintanar-Guerrero","year":"1998","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib17","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1023\/A:1018970030327","article-title":"In vitro extended release properties of drug-loaded poly (DL-Lactic acid) nanoparticles produced by salting-out procedure","volume":"10","author":"Allemann","year":"1993","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2009.04.008_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cep.2004.02.013","article-title":"The formation of fine particles by salting-out precipitation","volume":"44","author":"Toth","year":"2005","journal-title":"Chem Eng Process"},{"key":"10.1016\/j.nano.2009.04.008_bib19","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0378-5173(89)90281-0","article-title":"Nanocapsule formation by interfacial polymer deposition following solvent displacement","volume":"55","author":"Fessi","year":"1989","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0168-3659(98)00116-3","article-title":"PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug","volume":"57","author":"Govender","year":"1999","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jcis.2007.09.081","article-title":"Mechanism of nanocapsules formation by the emulsion\u2013diffusion process","volume":"317","author":"Moinard-Checot","year":"2008","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.nano.2009.04.008_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0378-5173(03)00135-2","article-title":"Preparation of solid lipid nanoparticles by a solvent emulsification\u2013diffusion technique","volume":"257","author":"Trotta","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0378-5173(95)00002-Z","article-title":"Biodegradable submicron carriers for peptide drugs: preparation of DL-lactide\/glycolide copolymer (PLGA) nanospheres with nafarelin acetate by a novel emulsion-phase separation method in an oil system","volume":"121","author":"Niwa","year":"1995","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0896-8446(01)00064-X","article-title":"Particle design using supercritical fluids: literature and patent survey","volume":"20","author":"Jung","year":"2001","journal-title":"J Supercrit Fluids"},{"key":"10.1016\/j.nano.2009.04.008_bib25","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.supflu.2006.11.002","article-title":"Growth of magnetic thin films using CO2 RESS expansions","volume":"42","author":"Dea","year":"2007","journal-title":"J Supercrit Fluids"},{"key":"10.1016\/j.nano.2009.04.008_bib26","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1021\/ie00038a051","article-title":"Solubility and micronization of griseofulvin in supercritical CHF3","volume":"34","author":"Reverchon","year":"1995","journal-title":"Ind Eng Chem Res"},{"key":"10.1016\/j.nano.2009.04.008_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0032-5910(99)00062-5","article-title":"Production of antibiotic micro- and nano-particles by supercritical antisolvent precipitation","volume":"10","author":"Reverchon","year":"1999","journal-title":"Powder Technol"},{"key":"10.1016\/j.nano.2009.04.008_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0378-5173(01)00803-1","article-title":"Production of griseofulvin nanoparticles using supercritical CO2 antisolvent with enhanced mass transfer","volume":"228","author":"Chattopadhyay","year":"2001","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib29","first-page":"51","article-title":"Particles from supercritical fluid extraction of emulsions (PSFEE): a new method for preparation of nanoparticles of poorly water soluble drugs","volume":"1","author":"Chattopadhyay","year":"2003","journal-title":"Pharm Technol"},{"key":"10.1016\/j.nano.2009.04.008_bib30","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/adfm.200600003","article-title":"Organic nanoparticles: preparation, self-assembly, and properties","volume":"16","author":"Jagannathan","year":"2006","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.nano.2009.04.008_bib31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijpharm.2007.05.012","article-title":"Bioeliminable polymeric nanoparticles for proteic drug delivery","volume":"343","author":"Chiellini","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(00)00339-4","article-title":"Biodegradable polymeric nanoparticles as drug delivery devices","volume":"70","author":"Soppimath","year":"2001","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2006.11.028","article-title":"Encapsulation of dexamethasone into biodegradable polymeric nanoparticles","volume":"331","author":"Gomez-Gaete","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2006.06.023","article-title":"PLA\/PLGA nanoparticles for sustained release of docetaxel","volume":"325","author":"Musumeci","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijpharm.2005.02.027","article-title":"Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly (\u03b3-benzyl L-glutamate) and poly (ethylene glycol) diblock copolymer endcapped with galactose moiety","volume":"296","author":"Jeong","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijpharm.2004.12.010","article-title":"Poly (ethylene oxide)-modified poly (\u03b3-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer","volume":"293","author":"Shenoy","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jconrel.2006.10.023","article-title":"Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats","volume":"117","author":"Damge","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ymeth.2005.11.003","article-title":"Diphtheria toxoid loaded poly-(\u03b3-caprolactone) nanoparticles as mucosal vaccine delivery systems","volume":"38","author":"Singh","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.nano.2009.04.008_bib39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijpharm.2006.08.007","article-title":"Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery","volume":"328","author":"Liu","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2006.07.026","article-title":"Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin","volume":"327","author":"Zhang","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib41","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijpharm.2008.01.008","article-title":"Solid lipid nanoparticles for pulmonary delivery of insulin","volume":"356","author":"Liu","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib42","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijpharm.2008.01.045","article-title":"Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation","volume":"357","author":"Puglia","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijpharm.2007.05.061","article-title":"Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery","volume":"345","author":"Shah","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2007.12.018","article-title":"Potential of solid lipid nanoparticles in brain targeting","volume":"127","author":"Kaur","year":"2008","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib45","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.addr.2007.04.011","article-title":"Solid lipid nanoparticles for targeted brain drug delivery","volume":"59","author":"Blasi","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2009.04.008_bib46","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.tube.2005.08.009","article-title":"Oral solid lipid nanoparticle-based antitubercular chemotherapy","volume":"85","author":"Pandey","year":"2005","journal-title":"Tuberculosis"},{"key":"10.1016\/j.nano.2009.04.008_bib47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1748-0132(07)70084-1","article-title":"Magnetic nanoparticles for drug delivery","volume":"2","author":"Arruebo","year":"2007","journal-title":"Nano Today"},{"key":"10.1016\/j.nano.2009.04.008_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1263\/jbb.100.1","article-title":"Medical application of functionalized magnetic nanoparticles","volume":"100","author":"Ito","year":"2005","journal-title":"J Biosci Bioeng"},{"key":"10.1016\/j.nano.2009.04.008_bib49","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1016\/j.biomaterials.2008.07.004","article-title":"Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging","volume":"29","author":"Jain","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2009.04.008_bib50","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1748-0132(07)70016-6","article-title":"Au nanoparticles target cancer","volume":"2","author":"Jain","year":"2007","journal-title":"Nano Today"},{"key":"10.1016\/j.nano.2009.04.008_bib51","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1021\/nl072471q","article-title":"Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles","volume":"7","author":"Giljohann","year":"2007","journal-title":"Nano Lett"},{"key":"10.1016\/j.nano.2009.04.008_bib52","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.addr.2008.03.012","article-title":"Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers","volume":"60","author":"Slowing","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2009.04.008_bib53","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.addr.2008.03.016","article-title":"Gold nanoparticles in delivery applications","volume":"60","author":"Ghosh","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2009.04.008_bib54","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1016\/j.biomaterials.2008.03.007","article-title":"Glutathione-mediated release of functional plasmid DNA from positively charged quantum dots","volume":"29","author":"Li","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2009.04.008_bib55","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.addr.2008.03.015","article-title":"Bioconjugated quantum dots for in vivo molecular and cellular imaging","volume":"60","author":"Smith","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2009.04.008_bib56","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1470-2045(06)70793-8","article-title":"Emerging use of nanoparticles in diagnosis and treatment of breast cancer","volume":"7","author":"Yezhelyev","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.nano.2009.04.008_bib57","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jconrel.2008.01.018","article-title":"Polymeric micelles in oral chemotherapy","volume":"128","author":"Bromberg","year":"2008","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib58","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jconrel.2007.05.038","article-title":"Mixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agents","volume":"122","author":"Bae","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib59","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.biomaterials.2006.11.039","article-title":"Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles","volume":"28","author":"Seow","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2009.04.008_bib60","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.progpolymsci.2007.05.009","article-title":"Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery","volume":"32","author":"Rapoport","year":"2007","journal-title":"Prog Polym Sci"},{"key":"10.1016\/j.nano.2009.04.008_bib61","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nano.2004.11.002","article-title":"Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine","volume":"1","author":"Koo","year":"2005","journal-title":"Nanomedicine"},{"issue":"2","key":"10.1016\/j.nano.2009.04.008_bib62","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.nano.2008.10.001","article-title":"Quantum dots encapsulated in phospholipid micelles for imaging and quantification of tumors in the near-infrared region","volume":"5","author":"Papagiannaros","year":"2009","journal-title":"Nanomedicine"},{"issue":"2","key":"10.1016\/j.nano.2009.04.008_bib63","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.nano.2008.09.001","article-title":"Self-associated indisulam in phospholipid-based nanomicelles: a potential nanomedicine for cancer","volume":"5","author":"Cesur","year":"2009","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2009.04.008_bib64","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.vaccine.2008.02.058","article-title":"Surface modified liposomes for nasal delivery of DNA vaccine","volume":"26","author":"Khatri","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2009.04.008_bib65","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ab.2008.05.027","article-title":"Fluorescently labeled liposomes for monitoring cholera toxin binding to epithelial cells","volume":"380","author":"Edwards","year":"2008","journal-title":"Anal Biochem"},{"key":"10.1016\/j.nano.2009.04.008_bib66","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0031-6997(24)01426-1","article-title":"Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors","volume":"51","author":"Drummond","year":"1999","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.nano.2009.04.008_bib67","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.canlet.2008.04.024","article-title":"Tumor targeting of vincristine by mBAFF-modified PEG liposomes in B lymphoma cells","volume":"269","author":"Zhang","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.nano.2009.04.008_bib68","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0168-3659(99)00048-6","article-title":"Pulmonary delivery of insulin with nebulized DL-lactide\/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect","volume":"62","author":"Kawashima","year":"1999","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib69","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0168-3659(99)00247-3","article-title":"Nanosphere based oral insulin delivery","volume":"65","author":"Carino","year":"2000","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib70","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1023\/A:1018911411381","article-title":"A heterogeneously structured composite based on poly (lactic-co-glycolic acid) micro spheres and poly (vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery","volume":"16","author":"Wang","year":"1999","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2009.04.008_bib71","first-page":"40","article-title":"Preparation and characterization of poly-\u025b-caprolactone particles for controlled insulin delivery","volume":"1","author":"Mukerjee","year":"2007","journal-title":"J Biomed Pharm Eng"},{"key":"10.1016\/j.nano.2009.04.008_bib72","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5173(02)00486-6","article-title":"Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo","volume":"249","author":"Pan","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib73","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1021\/bm049312a","article-title":"Preparation of nanoparticles composed of chitosan\/poly-\u03b3-glutamic acid and evaluation of their permeability through caco-2 cells","volume":"6","author":"Lin","year":"2005","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.nano.2009.04.008_bib74","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S1359-6446(03)02903-9","article-title":"Nanotech approaches to drug delivery and imaging","volume":"8","author":"Sahoo","year":"2003","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.nano.2009.04.008_bib75","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1023\/B:PHAM.0000036917.75634.be","article-title":"Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods","volume":"21","author":"Galindo-Rodriguez","year":"2004","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2009.04.008_bib76","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0378-5173(91)90128-B","article-title":"Approaches to improve the association of amikacin sulphate to poly-(cyanoacrylate) nanoparticles","volume":"68","author":"Alenso","year":"1991","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib77","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jconrel.2006.12.020","article-title":"Characterization of bio-nanocapsule as a transfer vector targeting human hepatocyte carcinoma by disulfide linkage modification","volume":"118","author":"Nagaoka","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib78","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jconrel.2007.06.019","article-title":"Development of bionanocapsules targeting brain tumors","volume":"122","author":"Tsutsui","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib79","first-page":"869","article-title":"Development of bio-nanocapsules and its applications in the biomedical field","volume":"57","author":"Sunichi","year":"2006","journal-title":"Chem Ind"},{"key":"10.1016\/j.nano.2009.04.008_bib80","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jconrel.2007.12.002","article-title":"Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials","volume":"126","author":"Jung","year":"2008","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib81","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.bmcl.2009.01.049","article-title":"Construction of arginine-rich peptide displaying bionanocapsules","volume":"19","author":"Shishido","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nano.2009.04.008_bib82","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejpb.2003.09.011","article-title":"Thiomers: development and in vitro evaluation of a peroral microparticulate peptide delivery system","volume":"57","author":"Krauland","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2009.04.008_bib83","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0928-0987(02)00245-2","article-title":"Mucoadhesive and cohesive properties of poly(acrylic acid)-cysteine conjugates with regard to their molecular mass","volume":"18","author":"Leitner","year":"2003","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2009.04.008_bib84","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.addr.2003.12.002","article-title":"Solid lipid nanoparticles for parenteral drug delivery","volume":"56","author":"Wissing","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2009.04.008_bib85","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1088\/0022-3727\/36\/13\/201","article-title":"Applications of magnetic nanoparticles in biomedicine","volume":"36","author":"Pankhurst","year":"2003","journal-title":"J Phys D Appl Phys"},{"key":"10.1016\/j.nano.2009.04.008_bib86","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00441-004-0884-8","article-title":"Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging","volume":"316","author":"Briley-Saebo","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.nano.2009.04.008_bib87","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.physc.2007.03.493","article-title":"A study on magnetically targeted drug delivery system using superconducting magnet","volume":"463","author":"Nishijima","year":"2007","journal-title":"Physica C"},{"key":"10.1016\/j.nano.2009.04.008_bib88","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0304-8853(00)01230-0","article-title":"Radiolabeling of magnetic particles with rhenium-188 for cancer therapy","volume":"225","author":"Hafeli","year":"2001","journal-title":"J Magn Magn Mater"},{"key":"10.1016\/j.nano.2009.04.008_bib89","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.apradiso.2004.03.114","article-title":"Preparation and radiolabeling of human serum albumin (HSA)-coated magnetite nanoparticles for magnetically targeted therapy","volume":"61","author":"Chunfu","year":"2004","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nano.2009.04.008_bib90","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jmmm.2005.02.038","article-title":"Magnetic targeting of aerosol particles for cancer therapy","volume":"293","author":"Ally","year":"2005","journal-title":"J Magn Magn Mater"},{"key":"10.1016\/j.nano.2009.04.008_bib91","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nnano.2007.217","article-title":"Targeted delivery of magnetic aerosol droplets to the lung","volume":"2","author":"Dames","year":"2007","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.nano.2009.04.008_bib92","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jaerosci.2008.04.003","article-title":"Enhanced deposition of high aspect ratio aerosols in small airway bifurcations using magnetic field alignment","volume":"39","author":"Martin","year":"2008","journal-title":"Aerosol Sci"},{"key":"10.1016\/j.nano.2009.04.008_bib93","first-page":"6641","article-title":"Locoregional cancer treatment with magnetic drug targeting","volume":"60","author":"Alexiou","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.nano.2009.04.008_bib94","first-page":"4694","article-title":"Preclinical experiences with magnetic drug targeting: tolerance and efficacy","volume":"56","author":"Lubbe","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.nano.2009.04.008_bib95","first-page":"5874","article-title":"Phase I clinical and pharmacokinetic study of mitoxantrone given to patients by intraperitoneal administration","volume":"48","author":"Alberts","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.nano.2009.04.008_bib96","doi-asserted-by":"crossref","first-page":"12696","DOI":"10.1021\/ja983183m","article-title":"Nanometer gold clusters protected by surface-bound mono-layers of thiolated poly (ethylene glycol) polymer electrolyte","volume":"12","author":"Wuelfing","year":"1998","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.nano.2009.04.008_bib97","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1246\/cl.2006.1046","article-title":"Smart PEGylated gold nanoparticles for the cytoplasmic delivery of siRNA to induce enhanced gene silencing","volume":"35","author":"Oishi","year":"2006","journal-title":"Chem Lett"},{"key":"10.1016\/j.nano.2009.04.008_bib98","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s11095-007-9257-9","article-title":"Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin","volume":"24","author":"Bhumkar","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2009.04.008_bib99","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/anie.200603404","article-title":"Controlled release of guest molecules from mesoporous silica particles based on a pH-responsive polypseudorotaxane motif","volume":"46","author":"Park","year":"2007","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.nano.2009.04.008_bib100","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.nano.2008.06.002","article-title":"Emerging nanopharmaceuticals","volume":"4","author":"Bawarski","year":"2008","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2009.04.008_bib101","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.bbrc.2005.02.043","article-title":"Quantum dots in bio-imaging: revolution by the small","volume":"329","author":"Arya","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nano.2009.04.008_bib102","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejpb.2007.05.013","article-title":"Polymer coating of quantum dots\u2014a powerful tool toward diagnostics and sensorics","volume":"68","author":"Hezinger","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2009.04.008_bib103","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1021\/nl0347334","article-title":"Probing the cytotoxicity of semiconductor quantum dots","volume":"4","author":"Derfus","year":"2004","journal-title":"Nano Lett"},{"key":"10.1016\/j.nano.2009.04.008_bib104","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.toxlet.2006.09.007","article-title":"CdSe quantum dots induce apoptosis in human neuroblastoma cells via mitochondrial-dependent pathways and inhibition of survival signals","volume":"167","author":"Chan","year":"2006","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.nano.2009.04.008_bib105","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.taap.2005.07.018","article-title":"A rapid and transient ROS generation by cadmium triggers apoptosis via caspase-dependent pathway in HepG2 cells and this is inhibited through N-acetylcysteine-mediated catalase upregulation","volume":"212","author":"Oh","year":"2006","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.nano.2009.04.008_bib106","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nbt1188","article-title":"Self-illuminating quantum dot conjugates for in vivo imaging","volume":"24","author":"So","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nano.2009.04.008_bib107","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1021\/nl052405t","article-title":"Peptide-labeled near-Infrared quantum dots for imaging tumor vasculature in living subjects","volume":"6","author":"Cai","year":"2006","journal-title":"Nano Lett"},{"key":"10.1016\/j.nano.2009.04.008_bib108","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nbt764","article-title":"Immunofluorescent labeling of cancer marker Her2 and other cellular target with semiconductor quantum dots","volume":"21","author":"Wu","year":"2002","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nano.2009.04.008_bib109","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1021\/ac010662m","article-title":"Conjugation of luminescent quantum dots with antibodies using an engineered adaptor protein to provide new reagents for fluoroimmunoassay","volume":"74","author":"Goldman","year":"2002","journal-title":"Anal Chem"},{"key":"10.1016\/j.nano.2009.04.008_bib110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijbiomac.2006.02.023","article-title":"The development of rapid fluorescence-based immunoassays, using quantum dot-labelled antibodies for the detection of Listeria monocytogenes cell surface proteins","volume":"39","author":"Tully","year":"2006","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.nano.2009.04.008_bib111","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1128\/AEM.70.1.597-598.2004","article-title":"Quantum dots as a novel immunofluorescent detection system for Cryptosporidium parvum and Giardia lamblia","volume":"70","author":"Zhu","year":"2004","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.nano.2009.04.008_bib112","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1021\/ac035083r","article-title":"Multiplexed toxin analysis using four colors quantum dot fluororeagents","volume":"76","author":"Goldman","year":"2004","journal-title":"Anal Chem"},{"key":"10.1016\/j.nano.2009.04.008_bib113","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2005.09.034","article-title":"Block copolymer micelles: preparation, characterization and application in drug delivery","volume":"109","author":"Gaucher","year":"2005","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib114","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2007.12.017","article-title":"A review of stimuli-responsive nanocarriers for drug and gene delivery","volume":"126","author":"Ganta","year":"2008","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2007.08.006","article-title":"Tumor pH-responsive flower-like micelles of poly (L-lactic acid)-b-poly (ethylene glycol)-b-poly(L-histidine)","volume":"123","author":"Lee","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib116","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jconrel.2004.12.018","article-title":"Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor","volume":"103","author":"Lee","year":"2005","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib117","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2005.07.017","article-title":"Polymeric micelles with a pH-responsive structure as intracellular drug carriers","volume":"108","author":"Wang","year":"2005","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib118","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-3659(00)00278-9","article-title":"Factors affecting acoustically triggered release of drugs from polymeric micelles","volume":"69","author":"Husseini","year":"2000","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib119","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3835(97)00218-8","article-title":"Ultrasonic activated drug delivery from Pluronic P- 105 micelles","volume":"118","author":"Munshi","year":"1997","journal-title":"Cancer Lett"},{"key":"10.1016\/j.nano.2009.04.008_bib120","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.canlet.2005.02.020","article-title":"Synergistic and tumour selective effects of chemotherapy and ultrasound treatment","volume":"232","author":"Myhr","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.nano.2009.04.008_bib121","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/00137696-200604020-00005","article-title":"Ultrasound enhanced chemotherapy of drug-resistant breast cancer tumors by micellar-encapsulated paclitaxel","volume":"4","author":"Howard","year":"2006","journal-title":"Am J Drug Deliv"},{"key":"10.1016\/j.nano.2009.04.008_bib122","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2006.07.007","article-title":"Molecular design of biodegradable polymeric micelles for temperature-responsive drug release","volume":"115","author":"Nakayama","year":"2006","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib123","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.reactfunctpolym.2007.07.056","article-title":"Thermal modulation of intracellular drug distribution using thermoresponsive polymeric micelles","volume":"67","author":"Nakayama","year":"2007","journal-title":"React Funct Polym"},{"key":"10.1016\/j.nano.2009.04.008_bib124","first-page":"177","article-title":"Sterically stabilized liposomes in cancer therapy and gene delivery","volume":"1","author":"Lasic","year":"1999","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.nano.2009.04.008_bib125","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/BF02716840","article-title":"Increased circulatory half-life of liposomes after conjugation with dextran","volume":"6","author":"Pain","year":"1984","journal-title":"J Biosci"},{"key":"10.1016\/j.nano.2009.04.008_bib126","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/S0142-9612(01)00050-3","article-title":"Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification","volume":"22","author":"Torchilin","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2009.04.008_bib127","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1748-0132(07)70083-X","article-title":"Targeted nanoparticles for cancer therapy","volume":"2","author":"Gu","year":"2007","journal-title":"Nano Today"},{"key":"10.1016\/j.nano.2009.04.008_bib128","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib129","doi-asserted-by":"crossref","first-page":"7668","DOI":"10.1158\/0008-5472.CAN-04-2550","article-title":"Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells","volume":"64","author":"Farokhzad","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.nano.2009.04.008_bib130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0378-5173(03)00132-7","article-title":"A PEGylated dendritic nanoparticulate carrier of fluorouracil","volume":"257","author":"Bhadra","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib131","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev.med.54.101601.152442","article-title":"Monoclonal antibody therapy for cancer","volume":"54","author":"Mehren","year":"2003","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.nano.2009.04.008_bib132","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/sj.bjc.6601576","article-title":"Integrins: roles in cancer development and as treatment targets","volume":"90","author":"Jin","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nano.2009.04.008_bib133","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.addr.2004.01.008","article-title":"Folate-targeted chemotherapy","volume":"56","author":"Leamon","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2009.04.008_bib134","first-page":"2807","article-title":"The biological chemistry of folate receptors","volume":"79","author":"Antony","year":"1992","journal-title":"J Am Soc Hematol"},{"key":"10.1016\/j.nano.2009.04.008_bib135","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0169-409X(02)00042-X","article-title":"Folate-mediated delivery of macromolecular anticancer therapeutic agents","volume":"54","author":"Lu","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2009.04.008_bib136","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0169-409X(99)00062-9","article-title":"Targeted drug delivery via the folate receptor","volume":"41","author":"Sudimack","year":"2000","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2009.04.008_bib137","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0928-0987(02)00055-6","article-title":"Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers","volume":"16","author":"Rege","year":"2002","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2009.04.008_bib138","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.biomaterials.2008.02.020","article-title":"Targeted delivery of paclitaxel using folate-decorated poly (lactide) evitamin E TPGS nanoparticles","volume":"29","author":"Pan","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2009.04.008_bib139","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0378-5173(02)00587-2","article-title":"Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticles","volume":"251","author":"Oyewumi","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib140","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous culture of fused cell secreting antibody of predefined specificity","volume":"256","author":"Kohler","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.nano.2009.04.008_bib141","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2007.03.012","article-title":"Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody","volume":"120","author":"Kocbek","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib142","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1016\/j.biomaterials.2006.05.016","article-title":"Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells","volume":"27","author":"Steinhauser","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2009.04.008_bib143","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1200\/JCO.2001.19.13.3244","article-title":"Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse","volume":"19","author":"Sievers","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nano.2009.04.008_bib144","first-page":"1490","article-title":"Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia","volume":"7","author":"Bross","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nano.2009.04.008_bib145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/nar\/gkh094","article-title":"Aptamer database","volume":"32","author":"Lee","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nano.2009.04.008_bib146","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase","volume":"249","author":"Gold","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.nano.2009.04.008_bib147","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tibtech.2008.04.006","article-title":"Nanotechnology and aptamers: applications in drug delivery","volume":"24","author":"Levy-Nissenbaum","year":"2008","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.nano.2009.04.008_bib148","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0172-2190(03)00035-8","article-title":"Aptamers and SELEX: the technology","volume":"25","author":"Sampson","year":"2003","journal-title":"World Pat Inf"},{"key":"10.1016\/j.nano.2009.04.008_bib149","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.aca.2008.05.031","article-title":"Applications of aptamers in cancer cell biology","volume":"621","author":"Phillips","year":"2008","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.nano.2009.04.008_bib150","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.cbpa.2006.03.015","article-title":"Aptamer therapeutics advance","volume":"10","author":"Lee","year":"2006","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.nano.2009.04.008_bib151","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.addr.2005.09.018","article-title":"Dendrimers in biomedical applications\u2014reflections on the field","volume":"57","author":"Svenson","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2009.04.008_bib152","first-page":"1","article-title":"Targeting cancer cells with biotin-dendrimer conjugates","author":"Yang","year":"2008","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.nano.2009.04.008_bib153","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.ejmech.2005.08.002","article-title":"Polyamidoamine dendrimers used as solubility enhancers of ketoprofen","volume":"40","author":"Yiyun","year":"2005","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.nano.2009.04.008_bib154","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijpharm.2005.02.036","article-title":"Hydrophobic dendrimer-derived nanoparticles","volume":"298","author":"Singh","year":"2005","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.nano.2009.04.008_bib155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2004.09.015","article-title":"Poly (amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide","volume":"102","author":"Vandamme","year":"2005","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib156","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.addr.2005.09.017","article-title":"Dendrimers in gene delivery","volume":"57","author":"Dufes","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2009.04.008_bib157","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S1367-5931(02)00350-2","article-title":"Anti-integrin as novel drug-discovery targets: potential therapeutic and diagnostic implications","volume":"6","author":"Mousa","year":"2002","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.nano.2009.04.008_bib158","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.nano.2005.03.008","article-title":"A review: integrin \u03b1v\u03b23-targeted molecular imaging and therapy in angiogenesis","volume":"1","author":"Lim","year":"2005","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2009.04.008_bib159","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0378-5173(03)00039-5","article-title":"Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats","volume":"255","author":"Dufes","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2009.04.008_bib160","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jconrel.2008.06.005","article-title":"Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles","volume":"130","author":"Wernig","year":"2008","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2009.04.008_bib161","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1208\/aapsj0902015","article-title":"Targeted pharmaceutical nanocarriers for cancer therapy and imaging","volume":"9","author":"Torchilin","year":"2007","journal-title":"AAPS J"},{"key":"10.1016\/j.nano.2009.04.008_bib162","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.addr.2004.02.014","article-title":"Nanoparticle and targeted systems for cancer therapy","volume":"56","author":"Brannon-Peppas","year":"2004","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154996340900094X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154996340900094X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T13:22:27Z","timestamp":1739107347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154996340900094X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":162,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S154996340900094X"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2009.04.008","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}